Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6947
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout ; volume:22 ; number:1 ; day:7 ; month:4 ; year:2022 ; pages:1-11 ; date:12.2022
BMC medical informatics and decision making ; 22, Heft 1 (7.4.2022), 1-11, 12.2022
- Urheber
-
Kampe, Ritch te
Boonen, Annelies
Jansen, Tim L.
Elling, Jan Mathis
Flendrie, Marcel
Eijk-Hustings, Yvonne van
Janssen, Matthijs
Durme, Caroline van
Vries, Hein de
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12911-022-01833-6
- URN
-
urn:nbn:de:101:1-2022062508471290503106
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kampe, Ritch te
- Boonen, Annelies
- Jansen, Tim L.
- Elling, Jan Mathis
- Flendrie, Marcel
- Eijk-Hustings, Yvonne van
- Janssen, Matthijs
- Durme, Caroline van
- Vries, Hein de
- SpringerLink (Online service)
Ähnliche Objekte (12)
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study